Genomic characterization of APEC phages and evaluation of the efficacy in reducing the loads of APEC O78 infections in chickens

TL;DR

This study identifies a phage that can reduce APEC O78 infections in chickens, offering a potential alternative to antibiotics.

Contribution

The study isolates and characterizes a new phage, LQ5, and demonstrates its efficacy in reducing APEC O78 bacterial loads in chickens.

Findings

Phage LQ5 belongs to the Myoviridae family and has a genome of 171,908 bp.

Phage LQ5 reduced APEC O78 bacterial loads in chicken liver and spleen compared to amoxicillin.

The study enriches the phage gene bank for APEC and supports phage-based biocontrol development.

Abstract

The resistance of avian pathogenic Escherichia coli (APEC) poses a serious challenge to the control of bacterial diseases in the poultry industry. Identification of useful phages as alternatives to antibiotics for APEC O78 is a priority.

The phage LQ5 was isolated from the contents of the chicken intestines. Whole-genome sequencing was performed using the Illumina NovaSeq 2500 platform, and then bioinformatics analysis was conducted on the genome. The application effect of LQ5 in the O78 infection model of chickens was systematically evaluated.

The phage LQ5 was identified as a member of Myoviridae by electron microscopy. Whole-genome sequencing showed that phage LQ5 is a double strand DNA virus with a genome of 171,908 bp containing active components, such as endolysin, holin lysis mediator. Comparison of the bacterial load of APEC in chicken liver and spleen tissue in samples treated with phage LQ5 and Amoxicillin showed that the phage LQ5 reduced the bacterial load compared with the antibiotic.

These results have enriched the information of the phage gene bank for APEC, laying the foundation for the development of targeted phage biocontrol agents against the APEC O78 strain.

Figures